Missense mutations of SLC22A18 have been found in a variety of cancer types including breast cancer, lung cancer and rhabdomyosarcoma, and aberrant splicing of this gene has been reported in multiple Wilms' tumor cases [13, 14]. This evidence concerns the gene SLC67A1 and cancer.